Cresco Labs (CRLBF) Asset Writedowns and Impairment (2020 - 2026)

Cresco Labs' Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at $741000.0 for Q1 2026.

• Quarterly Asset Writedowns and Impairment fell 17.85% year-over-year to $741000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $104.9 million (up 3600.33% YoY) and the FY2025 annual result came in at $105.1 million, up 10410.1% from the prior year.
• Asset Writedowns and Impairment was $741000.0 for Q1 2026 at Cresco Labs, down from $93.5 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $139.4 million in Q4 2022 and bottomed at -$2.5 million in Q2 2024.
• A 5-year average of $23.4 million and a median of $902000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment surged 23147.94% — and 2024, when it sank 5600.0%.
• Cresco Labs' Asset Writedowns and Impairment stood at $139.4 million in 2022, then slumped by 99.98% to $24000.0 in 2023, then sank by 5600.0% to -$1.3 million in 2024, then soared by 7181.14% to $93.5 million in 2025, then slumped by 99.21% to $741000.0 in 2026.
• Business Quant data shows CRLBF's Asset Writedowns and Impairment at $741000.0 in Q1 2026, $93.5 million in Q4 2025, and $2.4 million in Q3 2025.